Ponalrestat
Ponalrestat, an aldose reductase inhibitor, activates lipoprotein lipase (LPL) activity in the adipose tissue and alleviates the cachectic symptoms induced by B16 melanoma in mice.
Product Specifications
CAS Number
72702-95-5
Product Name Alternative
ICI 128436 | MK-538 | Ponalrestat
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
O=C (O) CC1=NN (CC2=CC=C (Br) C=C2F) C (C3=C1C=CC=C3) =O
Molecular Formula
C17H12BrFN2O3
Molecular Weight
391.19
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2- (3- (4-bromo-2-fluorobenzyl) -4-oxo-3,4-dihydrophthalazin-1-yl) acetic acid
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ELMO2-1270R 50 µg
Recombinant Rhesus Macaque ELMO2 Protein, His (Fc)-Avi-tagged
Sign In for Pricing
View Details 
MBS7011507-01 0.02 mg
Recombinant Staphylococcus aureus Holin-like protein CidA (cidA)
Sign In for Pricing
View Details MBS7011507-02 0.1 mg
Recombinant Staphylococcus aureus Holin-like protein CidA (cidA)
Sign In for Pricing
View Details MBS7011507-03 5x 0.1 mg
Recombinant Staphylococcus aureus Holin-like protein CidA (cidA)
Sign In for Pricing
View Details 